G3P: G3P, located in Burlington, Massachusetts, is a development-stage company focusing on the health effects of pectin-derived carbohydrates as supplements and the role of galectin-3 in health and disease. Partnering with leading scientists and clinicians globally, G3P explores the understanding of galectin-3 and its implications on heart, kidney, lung, and neurodegenerative diseases.
Founded in 2017, G3P's primary objective is to investigate galectin-3 and pectin-derived carbohydrates to gain insights into their roles in nutrition and illness. Currently, the company operates in an undisclosed industry, with no specific headquarters or publicly disclosed investment information.